Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)
China · Delayed Price · Currency is CNY 14.00
-1.53 (-9.85%)
Sep 10, 2026, 2:10 PM CST
SHE:002365 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 201.46 | 230.59 | 320.41 | 326.17 | 274.72 | 93.51 |
Trading Asset Securities | 634.58 | 687.89 | 600.16 | 630.1 | 557.5 | 454.02 |
Cash & Short-Term Investments | 836.03 | 918.47 | 920.57 | 956.27 | 832.22 | 547.53 |
Cash Growth | -10.20% | -0.23% | -3.73% | 14.91% | 52.00% | -26.83% |
Accounts Receivable | 208.06 | 124.97 | 161.79 | 171.53 | 187.23 | 332.27 |
Other Receivables | 3.64 | 5.44 | 6.14 | 6.33 | 8.12 | 11.63 |
Receivables | 211.7 | 130.41 | 167.93 | 177.86 | 195.35 | 343.9 |
Inventory | 100.91 | 90.89 | 93.5 | 69.9 | 149.6 | 145.78 |
Other Current Assets | 18.04 | 12.97 | 16.66 | 9.57 | 18.18 | 28.69 |
Total Current Assets | 1,167 | 1,153 | 1,199 | 1,214 | 1,195 | 1,066 |
Property, Plant & Equipment | 904.91 | 878.49 | 948.07 | 953.61 | 1,022 | 988.96 |
Long-Term Investments | 75.21 | 74.46 | 74.55 | 68.3 | 81.37 | 115.23 |
Goodwill | - | - | - | 0.52 | 8.77 | 8.77 |
Other Intangible Assets | 75.1 | 76.82 | 79.56 | 82.39 | 84.49 | 87.93 |
Long-Term Deferred Tax Assets | 3.68 | 11.41 | 5.84 | 11.26 | 9.73 | 9.94 |
Other Long-Term Assets | 2.85 | 6.74 | 1.93 | 17.46 | 22.03 | 9.21 |
Total Assets | 2,228 | 2,201 | 2,309 | 2,347 | 2,424 | 2,286 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 133.19 | 115.57 | 124.02 | 160.65 | 162.77 | 114.91 |
Accrued Expenses | 36.75 | 39.6 | 41.07 | 40.04 | 47.5 | 47 |
Short-Term Debt | 0.4 | 0.75 | 39.53 | 10.01 | 40.01 | 20.38 |
Current Income Taxes Payable | 12.95 | 8.91 | 7.06 | 7.84 | 0.61 | 2.37 |
Current Unearned Revenue | 21.64 | 20.1 | 19.28 | 15.59 | 11.77 | 21.53 |
Other Current Liabilities | 17.39 | 19.01 | 17.38 | 23.12 | 22.46 | 87.18 |
Total Current Liabilities | 222.31 | 203.94 | 248.34 | 257.26 | 285.13 | 293.37 |
Long-Term Unearned Revenue | 8.31 | 9.28 | 7.46 | 8.5 | 11.31 | 13.05 |
Long-Term Deferred Tax Liabilities | 1.21 | 5.5 | 10.75 | 33.09 | 24.74 | 22.53 |
Total Liabilities | 231.83 | 218.72 | 266.55 | 298.85 | 321.17 | 328.95 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 294.68 | 294.68 | 294.68 | 294.68 | 294.68 | 294.68 |
Additional Paid-In Capital | 722.3 | 722.3 | 714.44 | 712.92 | 712.78 | 712.23 |
Retained Earnings | 993.98 | 979.48 | 985.91 | 953.42 | 995.2 | 854.85 |
Treasury Stock | -40.48 | -40.48 | -24.18 | - | - | - |
Comprehensive Income & Other | 31.87 | 31.02 | 22.94 | 22.89 | 14.71 | 4.16 |
Total Common Equity | 2,002 | 1,987 | 1,994 | 1,984 | 2,017 | 1,866 |
Minority Interest | -5.76 | -5.07 | 48.28 | 64.38 | 85.63 | 91.06 |
Shareholders' Equity | 1,997 | 1,982 | 2,042 | 2,048 | 2,103 | 1,957 |
Total Liabilities & Equity | 2,228 | 2,201 | 2,309 | 2,347 | 2,424 | 2,286 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 0.4 | 0.75 | 39.53 | 10.01 | 40.01 | 20.38 |
Net Cash (Debt) | 835.64 | 917.72 | 881.04 | 946.26 | 792.2 | 527.15 |
Net Cash Growth | -6.89% | 4.16% | -6.89% | 19.45% | 50.28% | -15.78% |
Net Cash Per Share | 2.89 | 3.17 | 2.99 | 3.21 | 2.69 | 1.84 |
Filing Date Shares Outstanding | 289.71 | 289.15 | 289.15 | 294.68 | 294.68 | 294.68 |
Total Common Shares Outstanding | 289.71 | 289.15 | 291.24 | 294.68 | 294.68 | 294.68 |
Working Capital | 944.37 | 948.81 | 950.32 | 956.34 | 910.22 | 772.52 |
Book Value Per Share | 6.91 | 6.87 | 6.85 | 6.73 | 6.85 | 6.33 |
Tangible Book Value | 1,927 | 1,910 | 1,914 | 1,901 | 1,924 | 1,769 |
Tangible Book Value Per Share | 6.65 | 6.61 | 6.57 | 6.45 | 6.53 | 6.00 |
Buildings | - | 633.95 | 581.93 | 573.53 | 546.87 | 547.89 |
Machinery | - | 1,335 | 1,306 | 1,268 | 1,210 | 1,083 |
Construction In Progress | - | 18.9 | 66.41 | 26.12 | 51.55 | 43.07 |